Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.3277
-0.0223 (-6.37%)
Jul 30, 2026, 1:53 PM EDT
Aspira Women's Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -10.25 | -12.78 | -13.09 | -16.69 | -29.89 | -31.66 |
Depreciation & Amortization | 0.06 | 0.04 | 0.09 | 0.2 | 0.26 | 0.3 |
Other Amortization | 0.08 | 0.08 | - | - | - | - |
Asset Writedown & Restructuring Costs | 0 | 0 | 0.04 | 0.03 | 0.06 | 0 |
Stock-Based Compensation | 0.47 | 0.53 | 1.49 | 1.72 | 2.41 | 3.54 |
Other Operating Activities | 3.99 | 7.22 | -1.34 | -1.38 | -1.13 | -0.97 |
Change in Accounts Receivable | -0.32 | -0.22 | 0.47 | -0.21 | -0.22 | -0.16 |
Change in Inventory | -0.03 | 0.07 | -0.1 | 0.09 | -0.14 | -0.14 |
Change in Accounts Payable | 0.52 | -0.94 | 0.91 | 0.38 | -0.62 | 2.25 |
Change in Other Net Operating Assets | 1.21 | -1.02 | -0.59 | -0.03 | -1.82 | -0.55 |
Operating Cash Flow | -4.29 | -7.03 | -12.11 | -15.89 | -31.07 | -27.4 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.02 | -0.02 | -0.04 | -0.02 | -0.23 | -0.18 |
Sale (Purchase) of Intangibles | -0.39 | -0.39 | - | - | - | - |
Investing Cash Flow | -0.4 | -0.4 | -0.04 | -0.02 | -0.23 | -0.18 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 1.37 | - | - | - | - |
Long-Term Debt Repaid | - | -0.23 | -0.09 | -0.15 | -0.26 | -0.2 |
Total Debt Repaid | -0.23 | -0.23 | -0.09 | -0.15 | -0.26 | -0.2 |
Net Debt Issued (Repaid) | -0.23 | 1.13 | -0.09 | -0.15 | -0.26 | -0.2 |
Issuance of Common Stock | 3.09 | 6.57 | 10.28 | 6.1 | 9.01 | 48.95 |
Other Financing Activities | -0.14 | -0.29 | 0.88 | -0.73 | -1.33 | -0.38 |
Financing Cash Flow | 2.72 | 7.42 | 11.06 | 5.22 | 7.43 | 48.38 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -1.97 | -0.01 | -1.09 | -10.7 | -23.87 | 20.8 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.3 | -7.05 | -12.15 | -15.92 | -31.3 | -27.58 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -48.32% | -76.44% | -132.32% | -173.89% | -382.45% | -404.86% |
Free Cash Flow Per Share | -0.11 | -0.21 | -0.86 | -1.72 | -4.03 | -3.72 |
Levered Free Cash Flow | -4.45 | -6.71 | -7.88 | -9.72 | -19.71 | -15.52 |
Unlevered Free Cash Flow | -4.29 | -6.68 | -7.86 | -9.72 | -19.71 | -15.49 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.26 | 0.03 | 0.05 | 0.05 | 0.08 | 0.08 |
Change in Working Capital | 1.36 | -2.11 | 0.7 | 0.23 | -2.8 | 1.39 |